Nu Skin Enterprises, Inc. (NYSE:NUS) insider Joseph Y. Chang sold 36,503 shares of the company’s stock in a transaction dated Friday, November 10th. The stock was sold at an average price of $62.24, for a total transaction of $2,271,946.72. Following the completion of the transaction, the insider now owns 66,563 shares of the company’s stock, valued at approximately $4,142,881.12. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink.
Shares of Nu Skin Enterprises, Inc. (NUS) opened at $63.04 on Wednesday. The firm has a market cap of $3,349.59, a P/E ratio of 22.48, a PEG ratio of 2.31 and a beta of 1.57. Nu Skin Enterprises, Inc. has a one year low of $46.35 and a one year high of $65.85. The company has a quick ratio of 1.18, a current ratio of 1.78 and a debt-to-equity ratio of 0.44.
Nu Skin Enterprises (NYSE:NUS) last issued its quarterly earnings results on Wednesday, November 1st. The company reported $0.76 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.76. The company had revenue of $563.70 million during the quarter, compared to analyst estimates of $562.70 million. Nu Skin Enterprises had a net margin of 6.97% and a return on equity of 22.38%. The business’s revenue for the quarter was down 6.7% compared to the same quarter last year. During the same period in the prior year, the business posted $0.98 EPS. research analysts anticipate that Nu Skin Enterprises, Inc. will post 3.23 earnings per share for the current year.
The business also recently declared a quarterly dividend, which will be paid on Wednesday, December 6th. Stockholders of record on Friday, November 17th will be paid a $0.36 dividend. This represents a $1.44 dividend on an annualized basis and a dividend yield of 2.28%. The ex-dividend date of this dividend is Thursday, November 16th. Nu Skin Enterprises’s dividend payout ratio is currently 52.75%.
ILLEGAL ACTIVITY WARNING: This article was first reported by Sports Perspectives and is owned by of Sports Perspectives. If you are accessing this article on another publication, it was illegally copied and republished in violation of international copyright and trademark law. The original version of this article can be accessed at https://sportsperspectives.com/2017/11/15/joseph-y-chang-sells-36503-shares-of-nu-skin-enterprises-inc-nus-stock.html.
Large investors have recently modified their holdings of the company. US Bancorp DE lifted its stake in shares of Nu Skin Enterprises by 3.3% in the 2nd quarter. US Bancorp DE now owns 2,032 shares of the company’s stock worth $128,000 after acquiring an additional 65 shares during the period. Migdal Insurance & Financial Holdings Ltd. acquired a new stake in shares of Nu Skin Enterprises in the 3rd quarter worth approximately $148,000. CENTRAL TRUST Co acquired a new stake in Nu Skin Enterprises during the second quarter valued at approximately $187,000. Pillar Pacific Capital Management LLC acquired a new stake in Nu Skin Enterprises during the second quarter valued at approximately $202,000. Finally, Ronald Blue & Co. LLC acquired a new stake in Nu Skin Enterprises during the second quarter valued at approximately $207,000. 80.13% of the stock is owned by institutional investors.
Several research analysts have commented on the stock. ValuEngine upgraded shares of Nu Skin Enterprises from a “hold” rating to a “buy” rating in a research report on Tuesday. Zacks Investment Research cut shares of Nu Skin Enterprises from a “hold” rating to a “sell” rating in a research report on Tuesday, October 17th. TheStreet upgraded shares of Nu Skin Enterprises from a “c+” rating to a “b” rating in a research report on Wednesday, August 2nd. Stifel Nicolaus set a $50.00 target price on shares of Nu Skin Enterprises and gave the stock a “sell” rating in a research report on Thursday, August 3rd. Finally, BidaskClub cut shares of Nu Skin Enterprises from a “strong-buy” rating to a “buy” rating in a research report on Monday, July 31st. Three equities research analysts have rated the stock with a sell rating, two have assigned a hold rating and four have issued a buy rating to the company. The stock currently has a consensus rating of “Hold” and a consensus target price of $62.00.
About Nu Skin Enterprises
Nu Skin Enterprises, Inc is a direct selling company that develops and distributes personal care products and nutritional supplements, and a range of other products and services. The Company offers anti-aging personal care products and nutritional supplements under its Nu Skin and Pharmanex brands. The Nu Skin brand offers a range of products, including ageLOC Me customized skin care system, ageLOC Spa systems and ageLOC Transformation anti-aging skin care system.
Receive News & Ratings for Nu Skin Enterprises Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises Inc. and related companies with MarketBeat.com's FREE daily email newsletter.